The Dow Jones index fell 0.1% in morning trading, as the S&P 500 edged lower. The Nasdaq composite was down a fraction after the
Author: techrossm
Are stock markets open today on New Year 2026? Check list of BSE, NSE holidays this year
According to the list of holidays available on the National Stock Exchange (NSE), there will be 15 stock market holidays in 2026.
Dow Jones falls 300 points as Wall Street ends 2025 with fourth day of selling
The Dow Jones fell over 300 points to close at the lows of the day, while the S&P 500 and Nasdaq ended with losses
Stock market today: Trade guide for Nifty 50, gold price to silver rates — Eight stocks to buy or sell on 1 January 2025
Experts have recommended eight stocks to buy today — L&T Finance, BPCL, Union Bank of India, BSE Ltd, Bharti Airtel, Cemindia Projects, Tourism Finance
Dow Jones, stock market fall to key levels to end 2025; Tesla, Palantir, Nvidia chipmaker in focus
The stock market fell to end a solid 2025. Palantir and Nvidia chipmaker Taiwan Semi were in focus. Tesla deliveries loom.
PharmaCorp Announces Grant of Stock Options
SASKATOON, Saskatchewan, Dec. 31, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp ” or the “Corporation ”) (TSXV: PCRX) has granted a total of
Dow Jones futures: Market falls to key levels to end 2025; Tesla, Palantir, Nvidia, chipmaker in focus
The stock market fell to end a solid 2025. Palantir and Nvidia chipmaker Taiwan Semi were in focus. Tesla deliveries loom.
Stock market today: Indexes fall ahead of 2026; Bitcoin erases 2025 gain (live coverage)
While the major stock indexes were down, they were on track to book robust gains for the year. As of Tuesday’s close, the Dow
Dow, S&P 500 and Nasdaq end final session of 2025 lower, but stock market still logs 3rd straight year of big gains
The major U.S. equity indexes ended the final day of 2025 lower, but the stock market still logged impressive yearly gains for a third
Why Corcept Therapeutics stock crashed today and what comes next?
Corcept stock tanks as FDA setback hits relacorilant for Cushing’s syndrome. Truist analysts believe CORT shares pullback may be overdone.